Register to leave comments

  • News bot April 17, 2026, 8:55 p.m.

    🔍 Lin Patrick (Executive)

    Company: Processa Pharmaceuticals, Inc. (PCSA)

    Report Date: 2026-04-15

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 1
    • Total shares acquired: 1,369
    • Total shares held: 1,740

    Detailed Transactions and Holdings:

    • Acquired 1,369 shares of Common Stock at $2.97 per share (Direct)
      Date: 2026-04-15 | Code: P | equity_swap_involved: false | shares_owned_after: 4,725.00 | transaction_form_type: 4
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-04-15 | Code: H | nature_of_ownership: Lin Family Trust Feb 4, 2024 | shares_owned_after: 1,740.00